{"lastClose": 2.5, "len": 420, "date": "2023-02-15", "alpha_1": -0.4120711740971271, "beta_1": 1.6437214552078077, "drawup_1": 1.2472826923210234, "natr_1": 26.15157923304049, "sup_1": -0.5813332875569663, "res_1": 0.9573333104451496, "bullPattern_1": [], "bearPattern_1": ["BELTHOLD", "HIKKAKE"], "rsi_1": 33.55931915725889, "adx_1": 15.803129881879986, "drawdown_1": -0.6977025560315342, "stratHoldSharpe_1": -0.7937312123969061, "stratHoldAlpha_1": 250.4215782395432, "stratHoldDrawdown_1": -0.6391384784860094, "alpha_3mo": -0.7825723750087725, "beta_3mo": 1.6943359946420895, "drawup_3mo": 0.28776976998181425, "natr_3mo": 26.15157923304049, "sup_3mo": -0.08599993387858085, "res_3mo": 0.024000040690104106, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 20.454545044045126, "adx_3mo": 43.21140004918272, "drawdown_3mo": -0.4305239006757945, "stratHoldSharpe_3mo": -3.39662709980213, "stratHoldAlpha_3mo": 249.07333820461832, "stratHoldDrawdown_3mo": -0.38747151060821516, "Sector": "Health Care", "IPO Year": 2021.0, "Industry": "Biotechnology: Pharmaceutical Preparations", "Market Cap": 624560696, "Name": "Lyell Immunopharma Inc.", "Country": "United States", "alpha%_1": 0.14736785556525067, "beta%_1": 0.8993488272416534, "drawup%_1": 0.9730707419898772, "natr%_1": 1.0, "drawdown%_1": 0.05831079577109517, "stratHoldSharpe%_1": 0.09503543093367306, "stratHoldAlpha%_1": 0.0073187937603695795, "stratHoldDrawdown%_1": 0.056393043941060865, "alpha%_3mo": 0.06731102469564948, "beta%_3mo": 0.90456896136873, "drawup%_3mo": 0.5730234181958171, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0002671892302768877, "stratHoldSharpe%_3mo": 0.0024407734159518813, "stratHoldAlpha%_3mo": 2.1625978544658542e-05, "stratHoldDrawdown%_3mo": 0.00029044068106663266}